生体吸収性インプラントの世界市場

生体吸収性インプラントの世界市場は2030年までに87億米ドルに達する見込み

2024年に59億米ドルと推定される生体吸収性インプラントの世界市場は、分析期間2024-2030年にCAGR 6.7%で成長し、2030年には87億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである金属インプラントは、CAGR 5.3％を記録し、分析期間終了までに49億米ドルに達すると予想されています。ポリマーインプラントセグメントの成長率は、分析期間中CAGR 8.7%と推定されます。

米国市場は16億米ドルと推定、中国はCAGR10.3％で成長予測

米国の生体吸収性インプラント市場は、2024年に16億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに18億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは10.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4％と6.4％と予測されています。欧州では、ドイツがCAGR 4.4%で成長すると予測されています。

世界の生体吸収性インプラント市場- 主要動向と促進要因のまとめ

生体吸収性インプラントが次世代外科手術や整形外科手術で戦略的重要性を増している理由とは？

生体吸収性インプラントは、時間の経過とともに自然に分解・吸収される一時的な構造サポートを提供することで、術後の治癒を再定義し、二次的な除去手術の必要性を排除します。これらのインプラントは、ポリ乳酸（PLA）、ポリグリコール酸（PGA）、マグネシウムベースの合金などの材料から設計されており、その生体適合性、長期合併症の減少、フォローアップ治療におけるコスト削減により、整形外科、心血管インターベンション、頭蓋顎顔面再建、スポーツ医学の分野で支持を集めています。

これらのインプラントの戦略的意義は、回復の早さ、手術負担の軽減、感染リスクの低減を重視する、低侵襲で患者中心のヘルスケアモデルとの整合性にあります。精密医療とバイオエンジニアリングが融合するにつれ、生体吸収性インプラントは、一時的な機械的完全性で十分であり、永久的なハードウェアの保持よりも組織の再生や自然治癒が優先される用途において、好ましい選択肢となりつつあります。

材料科学の進歩と生体工学の革新は、インプラントの性能をどのように向上させているのでしょうか？

ポリマー化学、合金設計、表面改質における革新は、強度の向上、劣化速度の制御、組織統合特性を備えた次世代の生体吸収性インプラントの開発を可能にしています。ポリマーをベースとしたインプラントは、機械的弾力性を高める複合材料のブレンドや添加物製造技術を用いて、荷重を支える用途に最適化されつつあります。特にマグネシウムベースのインプラントは、良好な生分解性と骨伝導性を備えており、整形外科や外傷関連の治療に理想的です。

表面コーティングと構造設計の強化により、細胞接着が改善され、炎症反応が最小限に抑えられています。また、3Dプリンティングと足場ベースの設計により、患者固有のカスタマイズが可能になっています。心臓血管への応用では、薬物溶出性の生体吸収性ステントが開発されており、再狭窄を減少させるとともに、治癒後に徐々に消失していきます。このような技術的アップグレードにより、永久インプラントから再吸収性インプラント戦略へ移行できる手技の範囲が拡大し、このカテゴリーが生物学的に整合した外科技術革新の最前線に位置づけられるようになっています。

生体吸収性インプラントの需要が高まっている場所と、採用をリードしている臨床セグメントとは？

北米と欧州では、手術件数が多いこと、規制の枠組みが整っていること、整形外科、スポーツ医学、小児医療において再吸収性技術が臨床的に受け入れられていることが、需要を加速させています。アジア太平洋は、特に日本、韓国、中国、インドにおいて高成長地域として浮上しており、医療費の増加、医療ツーリズム、外科医養成プログラムが、外傷、歯科、再建手術での採用を促進しています。

主な臨床分野には、スクリュー、ピン、プレートなどの整形外科用固定器具、関節鏡手術における軟組織アンカー、小児・外傷手術用の頭蓋顎顔面インプラント、冠動脈インターベンション用の血管スキャフォールドなどがあります。生体吸収性インプラントは、再手術の必要性を減らし、自然な成長に対応するためです。歯科や耳鼻咽喉科の外科医もサイナスリフト、骨移植、鼓膜修復に生体吸収性ソリューションを取り入れており、使用事例を広げています。

生体吸収性インプラント市場の世界的成長の原動力は？

世界の生体吸収性インプラント市場は、患者の安全性の優先、手術の革新、医療システムの効率性の合流によって牽引されています。医療行為が生物学的に統合された低侵襲のソリューションへとシフトする中、生体吸収性インプラントは合併症発生率の低下、長期的なハードウェアの存在感の低減、抜去処置の排除といった価値を提供します。保険償還の枠組み、規制当局の承認、臨床エビデンスの増加は、主要な専門分野での主流導入を後押ししています。

機器メーカー、研究機関、生体材料サプライヤー間の戦略的提携は、技術革新のパイプラインを加速させ、生分解性添加剤製造と材料検証への投資は、拡張性を向上させています。次世代インプラントが外科医のニーズと手技の多様性を満たすように進化する中、将来の勢いを形作る決定的な疑問があります。生体吸収性インプラント技術は、臨床的信頼性、機械的性能、そして費用対効果を、より幅広い解剖学的領域や外科領域にわたって提供し続けることができるのだろうか。

セグメント

材料（金属、ポリマー）、用途（整形外科、心臓血管、その他の用途）、エンドユーザー（病院、専門クリニック、外来手術センター、その他のエンドユーザー）

調査対象企業の例（全36件）

• Abbott Laboratories
• 4D Biomaterials
• Bioretec Ltd
• Boston Scientific Corporation
• CONMED Corporation
• Corbion N.V.
• DePuy Synthes（Johnson & Johnson）
• DSM Biomedical
• Evonik Industries AG
• Foster Corporation
• KLS Martin Group
• Lattice Medical
• Medtronic plc
• Meril Life Sciences
• MicroPort Scientific Corporation
• Poly-Med Inc.
• REVA Medical, Inc.
• Smith & Nephew plc
• Straumann Group
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、人為的な売上原価の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

Global Industry Analystsは、世界の主要なチーフ・エコノミスト（1万4,949人）、シンクタンク（62団体）、貿易・産業団体（171団体）の専門家の意見に熱心に従いながら、エコシステムへの影響を評価し、新たな市場の現実に対処しています。あらゆる主要国の専門家やエコノミストが、関税とそれが自国に与える影響についての意見を追跡調査しています。

Global Industry Analystsは、この混乱が今後2-3ヶ月で収束し、新しい世界秩序がより明確に確立されると予想しています。Global Industry Analystsは、これらの開発をリアルタイムで追跡しています。

2025年4月：交渉フェーズ

4月のリリースでは、世界市場全体に対する関税の影響を取り上げ、地域別の市場調整について紹介します。当社の予測は、過去のデータと進化する市場影響要因に基づいています。

2025年7月：最終関税リセット

お客様には、各国間で最終リセットが発表された後、7月に無料アップデート版をお届けします。最終アップデート版には、明確に定義された関税影響分析が組み込まれています。

相互および二国間貿易と関税の影響分析：

アメリカ <>中国<>メキシコ <>カナダ <>EU <>日本<>インド <>その他176カ国

業界をリードするエコノミスト：Global Industry Analystsの知識ベースは、国家、シンクタンク、貿易・産業団体、大企業、そして世界の計量経済状況におけるこの前例のないパラダイムシフトの影響を共有する領域の専門家など、最も影響力のあるチーフエコノミストの厳選されたグループを含む1万4,949人のエコノミストを追跡しています。我々の16,491以上のレポートのほとんどは、マイルストーンに基づくこの2段階のリリーススケジュールを取り入れています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Bioresorbable Implants Market to Reach US$8.7 Billion by 2030

The global market for Bioresorbable Implants estimated at US$5.9 Billion in the year 2024, is expected to reach US$8.7 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Metallic Implants, one of the segments analyzed in the report, is expected to record a 5.3% CAGR and reach US$4.9 Billion by the end of the analysis period. Growth in the Polymer Implants segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 10.3% CAGR

The Bioresorbable Implants market in the U.S. is estimated at US$1.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.8 Billion by the year 2030 trailing a CAGR of 10.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Global Bioresorbable Implants Market - Key Trends & Drivers Summarized

Why Are Bioresorbable Implants Gaining Strategic Importance in Next-Generation Surgical and Orthopedic Procedures?

Bioresorbable implants are redefining post-surgical healing by offering temporary structural support that naturally degrades and is absorbed by the body over time, eliminating the need for secondary removal surgeries. These implants-engineered from materials such as polylactic acid (PLA), polyglycolic acid (PGA), and magnesium-based alloys-are gaining traction across orthopedics, cardiovascular interventions, craniomaxillofacial reconstruction, and sports medicine due to their biocompatibility, reduced long-term complications, and cost savings in follow-up care.

The strategic relevance of these implants lies in their alignment with minimally invasive, patient-centric healthcare models that emphasize faster recovery, reduced surgical burden, and lower risk of infection. As precision medicine and bioengineering converge, bioresorbable implants are becoming a preferred choice in applications where temporary mechanical integrity is sufficient, and where tissue regeneration or natural healing is prioritized over permanent hardware retention.

How Are Material Science Advances and Bioengineering Innovations Enhancing Implant Performance?

Innovations in polymer chemistry, alloy design, and surface modification are enabling the development of next-generation bioresorbable implants with improved strength, controlled degradation rates, and tissue-integration properties. Polymer-based implants are being optimized for load-bearing applications using composite blends and additive manufacturing techniques that enhance mechanical resilience. Magnesium-based implants, in particular, offer favorable biodegradability and osteoconductivity-making them ideal for orthopedic and trauma-related interventions.

Surface coatings and structural design enhancements are improving cellular attachment and minimizing inflammatory responses, while 3D printing and scaffold-based designs are allowing for patient-specific customization. In cardiovascular applications, drug-eluting bioresorbable stents are being developed to reduce restenosis while gradually disappearing post-healing. These technological upgrades are expanding the scope of procedures that can transition from permanent to resorbable implant strategies-positioning the category at the forefront of biologically aligned surgical innovation.

Where Is Demand for Bioresorbable Implants Rising and Which Clinical Segments Are Leading Adoption?

Demand is accelerating in North America and Europe, driven by high surgical volumes, favorable regulatory frameworks, and clinical acceptance of resorbable technologies in orthopedics, sports medicine, and pediatric care. Asia-Pacific is emerging as a high-growth region, particularly in Japan, South Korea, China, and India, where increasing healthcare expenditure, medical tourism, and surgeon training programs are fostering adoption across trauma, dental, and reconstructive procedures.

Key clinical segments include orthopedic fixation devices such as screws, pins, and plates; soft-tissue anchors in arthroscopic procedures; craniomaxillofacial implants for pediatric and trauma surgeries; and vascular scaffolds for coronary interventions. Pediatric and trauma cases represent especially strong adoption drivers, as bioresorbable implants reduce the need for follow-up surgery and accommodate natural growth. Dental and ENT surgeons are also integrating bioresorbable solutions for sinus lifts, bone grafts, and tympanic membrane repair-broadening the use-case landscape.

What Is Fueling the Global Growth of the Bioresorbable Implants Market?

The global bioresorbable implants market is being driven by a confluence of patient safety priorities, surgical innovation, and health system efficiency. As medical practice shifts toward biologically integrated and minimally invasive solutions, bioresorbable implants offer value through lower complication rates, reduced long-term hardware presence, and elimination of explant procedures. Reimbursement frameworks, regulatory approvals, and growing clinical evidence are supporting mainstream adoption across key specialties.

Strategic collaborations between device manufacturers, research institutions, and biomaterials suppliers are accelerating innovation pipelines, while investments in biodegradable additive manufacturing and material validation are improving scalability. As next-generation implants evolve to meet surgeon needs and procedural diversity, a defining question shapes future momentum: Can bioresorbable implant technologies continue to deliver clinical reliability, mechanical performance, and cost-effectiveness across a broader range of anatomies and surgical disciplines-while advancing the standard of care in restorative medicine?

SCOPE OF STUDY:

The report analyzes the Bioresorbable Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Material (Metallic, Polymer); Application (Orthopedic, Cardiovascular, Other Applications); End-User (Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

• Abbott Laboratories
• 4D Biomaterials
• Bioretec Ltd
• Boston Scientific Corporation
• CONMED Corporation
• Corbion N.V.
• DePuy Synthes (Johnson & Johnson)
• DSM Biomedical
• Evonik Industries AG
• Foster Corporation
• KLS Martin Group
• Lattice Medical
• Medtronic plc
• Meril Life Sciences
• MicroPort Scientific Corporation
• Poly-Med Inc.
• REVA Medical, Inc.
• Smith & Nephew plc
• Straumann Group
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Bioresorbable Implants - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Focus on Temporary Support Structures Fuels Adoption of Bioresorbable Implant Technologies
  • Orthopedic and Cardiovascular Surgeries Lead Market Demand for Absorbable Implant Materials
  • Elimination of Second Surgeries for Implant Removal Drives Healthcare System Efficiency Gains
  • Innovations in Magnesium, Polylactic Acid, and Polymer Composites Expand Resorption Capabilities
  • Regulatory Approvals in Europe and the U.S. Accelerate Commercialization of Bioresorbable Devices
  • Pediatric and Sports Medicine Applications Favor Bioabsorbable Implants for Growth Accommodation
  • Biocompatibility and Mechanical Strength Optimization Define Competitive Landscape in Implant Design
  • Imaging Compatibility and Degradation Traceability Become Key Considerations for Surgeons
  • Expanding Clinical Evidence Base Validates Long-Term Safety and Efficacy of Resorbable Implants
  • Minimally Invasive Surgery Trends Support Market Expansion of Smaller, Absorbable Implant Formats
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Bioresorbable Implants Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Bioresorbable Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Bioresorbable Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Bioresorbable Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Metallic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Metallic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• JAPAN
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• CHINA
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• EUROPE
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Bioresorbable Implants by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Bioresorbable Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• FRANCE
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• GERMANY
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for Bioresorbable Implants by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for Bioresorbable Implants by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• INDIA
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for Bioresorbable Implants by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for Bioresorbable Implants by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for Bioresorbable Implants by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for Bioresorbable Implants by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030
• AFRICA
  • Bioresorbable Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for Bioresorbable Implants by Material - Metallic and Polymer - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for Bioresorbable Implants by Material - Metallic and Polymer Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for Bioresorbable Implants by Material - Percentage Breakdown of Value Sales for Metallic and Polymer for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Bioresorbable Implants by Application - Orthopedic, Cardiovascular and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for Bioresorbable Implants by Application - Percentage Breakdown of Value Sales for Orthopedic, Cardiovascular and Other Applications for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Bioresorbable Implants by End-user - Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for Bioresorbable Implants by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Ambulatory Surgery Centers and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION